ID16373A - Senyawa-senyawa baru - Google Patents

Senyawa-senyawa baru

Info

Publication number
ID16373A
ID16373A IDP970881A ID970881A ID16373A ID 16373 A ID16373 A ID 16373A ID P970881 A IDP970881 A ID P970881A ID 970881 A ID970881 A ID 970881A ID 16373 A ID16373 A ID 16373A
Authority
ID
Indonesia
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
IDP970881A
Other languages
English (en)
Inventor
Laramie Marie Dr Gaster
Peter Dr Ham
Francis David Dr King
Paul Andrian Dr Wyman
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID16373A publication Critical patent/ID16373A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IDP970881A 1996-03-20 1997-03-18 Senyawa-senyawa baru ID16373A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9605883.9A GB9605883D0 (en) 1996-03-20 1996-03-20 Novel compounds

Publications (1)

Publication Number Publication Date
ID16373A true ID16373A (id) 1997-09-25

Family

ID=10790741

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970881A ID16373A (id) 1996-03-20 1997-03-18 Senyawa-senyawa baru

Country Status (12)

Country Link
US (1) US6100272A (id)
EP (1) EP0888358A1 (id)
JP (1) JP2000507240A (id)
AR (1) AR007766A1 (id)
AU (1) AU2158197A (id)
CA (1) CA2250016A1 (id)
GB (1) GB9605883D0 (id)
ID (1) ID16373A (id)
PE (1) PE56198A1 (id)
UY (1) UY24491A1 (id)
WO (1) WO1997034901A1 (id)
ZA (1) ZA972329B (id)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000039103A1 (en) 1998-12-23 2000-07-06 Aventis Pharma Limited Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines
AU2001243394A1 (en) * 2000-03-02 2001-09-12 Smith Kline Beecham Corporation Compounds and methods
ATE416168T1 (de) 2002-02-15 2008-12-15 Glaxo Group Ltd Modulatoren des vanilloidrezeptors
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
TW202515885A (zh) * 2023-08-18 2025-04-16 大陸商江蘇恆瑞醫藥股份有限公司 稠合雜芳基類化合物、其製備方法及其在醫藥上的應用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2162792T3 (es) * 1991-09-18 2002-01-16 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d.
GB9119920D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
FR2699918B1 (fr) * 1992-12-30 1995-03-17 Pf Medicament Ligands sélectifs des récepteurs 5HY1D-5HT1B dérivés d'indole-pipérazine utiles comme médicaments.
GB9326008D0 (en) * 1993-12-21 1994-02-23 Smithkline Beecham Plc Novel compounds
EP0670313A1 (en) * 1994-03-04 1995-09-06 Takeda Chemical Industries, Ltd. Spiro compounds, their production and use
GB9421003D0 (en) * 1994-10-18 1994-12-07 Smithkline Beecham Plc Novel compounds
US5972951A (en) * 1994-12-22 1999-10-26 Smithkline Beecham Plc Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists
GB9519033D0 (en) * 1995-09-18 1995-11-15 Smithkline Beecham Plc Treatment
FR2761069A1 (fr) * 1997-03-20 1998-09-25 Pf Medicament Spiroamines derivees de dihydrobenzofuranes, leur preparation et leur application comme medicaments

Also Published As

Publication number Publication date
CA2250016A1 (en) 1997-09-25
UY24491A1 (es) 1997-09-12
US6100272A (en) 2000-08-08
PE56198A1 (es) 1998-12-10
JP2000507240A (ja) 2000-06-13
ZA972329B (en) 1998-09-18
GB9605883D0 (en) 1996-05-22
WO1997034901A1 (en) 1997-09-25
EP0888358A1 (en) 1999-01-07
AU2158197A (en) 1997-10-10
AR007766A1 (es) 1999-11-24

Similar Documents

Publication Publication Date Title
ID21881A (id) Turunan-turunan baru pirazol tersubstitusi
ID16660A (id) Senyawa-senyawa b-laktam monosiklik baru
ID17686A (id) Fotoinisiator alpha-aminoasetofenon baru
ID15881A (id) Oksazolidinan tersubstitusi yang baru
ID15840A (id) Turunan-turunan 19-nor-pregnena baru
ID18759A (id) Imidazole tersubstitusi sikloalkil baru
ID19609A (id) Senyawa-senyawa heterosiklik
ID19403A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
ID21850A (id) Formula senyawa baru
ID27263A (id) Dihidropirimidina baru
ID15904A (id) Senyawa-senyawa tiofenopirimidina
ID19476A (id) Senyawa piridilpirol
ID18685A (id) Senyawa trisiklik tersubstitusi
DE69716924D1 (de) Phosphonat-nukleotid-verbindungen
ID18431A (id) Senyawa-senyawa baru
BR9705635A (pt) Compostos
ID17421A (id) Senyawa senyawa baru
ID26299A (id) Herbisida baru
DK0923594T3 (da) Bromotiacumicinforbindelser
ID18262A (id) Turunan-turunan baru piranosida
ID16247A (id) Metode baru
ID19433A (id) Senyaw-senyawa baru
ID16684A (id) Senyawa-senyawa sulfonilurea baru
ID24191A (id) Komposisi baru